Accelerate your business with Oracle’s contract research organization (CRO) Growth Initiative

Gain a competitive edge, win more sponsor business, and execute more clinical trials efficiently and cost effectively with Oracle’s CRO Growth Initiative.

Accelerate your business

In the world of clinical research, speed, while maintaining quality and safety, is crucial. We recognize CROs are racing to attract and win more sponsor business, so we designed Oracle’s CRO Growth Initiative to include an accelerator. It provides you with unique go-to-market benefits, technical enablers, and incentives that empower you to plan, execute, measure, and reward your success in delivering your expert services with the industry’s leading clinical technology platform, Oracle Life Sciences Clinical One.

What are the benefits?

Partnership management

Dedicated CRO-focused resources to help accelerate your services growth and success based on a mutually agreed business strategy.

Free training and enablement

Clinical One accreditation and flexible and robust training programs to help build sales and services expertise to win new business.

Business development support

Go-to-market strategy to help elevate your brand and RFx support for joint selling and bid defenses.

Growth incentives

Clinical One single trial service credits and a free non-production Clinical One cloud environment for 12 months.

Why Oracle?

Oracle is committed to providing innovative, future-proof clinical and safety solutions that support crucial services that you provide throughout the clinical development lifecycle—from study design and startup to conduct, closeout, and post-marketing. Gain a competitive edge to win more business using proven and trusted clinical systems that can support any trial size and therapeutic area to meet the needs of your customers and patients.

About 10M

adverse events processed last year


unique health authorities were data beneficiaries


of all vaccine adverse events reported to the FDA1

More than 3M

safety cases supported last year from a single client2

More than 250K

total clinical studies managed

28 of 30

top pharmaceutical companies worldwide use Oracle clinical systems

1 Vaccine Adverse Event Reporting System (VAERS) publicly available datasets, 2017 to 2022 week 19.

2 Data from single customer.

Why are CROs collaborating with Oracle to grow their business?

accelsiors logo

“The free enablement and non-production environment for Clinical One has empowered our study build team and data managers to become SMEs in a very short timeframe which allows Accelsiors to deliver successful studies to their sponsors.”

Philippe Andry VP Data Management & Data Integration, Accelsiors
eclevar logo

“Oracle's CRO Growth Initiative has elevated Oracle's commitment to CROs in reducing the barriers to adopting new technology to meet the needs of our customers, all at no risk to us.”

Chems Hachani CEO Eclevar Medtech
everest logo

“We're excited to join the CRO Growth Initiative. With no risk, trials credits, and additional support, it just made good business sense.”

Ivan Pessotto Senior Director, Clinical Data Management, Everest Clinical Research
fhi logo

“FHI Clinical chose Oracle's Clinical One platform as our default clinical system because it is built the way we would have built for ourselves - single data source, united platform, intuitive, and cost efficient.”

Rob King Senior Director, Chief Operating Officer, FHI Clinical
sermes logo

“As a growing CRO, we are excited that Oracle, Oracle's CRO Growth Initiative and Clinical One are supporting our business goals to grow and address new markets.”

Antonio Berlanga CEO Sermes CRO

Get started with Oracle’s CRO Growth Initiative

Contact us

Please contact us to inquire about participating in the CRO Growth Initiative.